NEW YORK–(BUSINESS WIRE)–UBS Investment Bank today announced the recent listing of seven new 2x Leveraged US Factor ETNs specified in the table below.

 

ETN Ticker

ETN Name

ETN CUSIP

Underlying Index Bloomberg Ticker

SCDL

ETRACS 2x Leveraged US Dividend Factor TR ETN

90278V206

DJUSDIVT

IWFL

ETRACS 2x Leveraged US Growth Factor TR ETN

90278V305

RU10GRTR

IWML

ETRACS 2x Leveraged US Size Factor TR ETN

90278V404

RU20INTR

IWDL

ETRACS 2x Leveraged US Value Factor TR ETN

90278V107

RU10VATR

USML

ETRACS 2x Leveraged MSCI US Minimum Volatility Factor TR ETN

90278V701

M00IMV$T

MTUL

ETRACS 2x Leveraged MSCI US Momentum Factor TR ETN

90278V602

M2US000$

QULL

ETRACS 2x Leveraged MSCI US Quality Factor TR ETN

90278V503

M2USSNQ

 

About the Dow Jones US Dividend 100 TR USD Index

The Dow Jones US Dividend 100 TR USD Index is designed to track a basket of 100 high dividend-paying U.S. companies, excluding REITS, with a record of consistently paying dividends, selected based on financial ratios for fundamental strength relative to their peers. The Index is a total return index calculated by S&P Dow Jones and is weighted by float-adjusted market capitalization, subject to caps applied to individual constituents and sectors. The Index was publicly disseminated starting from August 31, 2011 and has no live performance history prior to that date.

About the Russell 1000 Growth TR USD Index

The Russell 1000 Growth TR USD Index measures the performance of large- and mid- capitalization U.S. equities that exhibit growth characteristics. It includes those Russell 1000® companies with higher price-to-book ratios and higher forecasted growth values. The Index is a total return index calculated by FTSE Russell and reinvests regular cash distributions across the Index. The Index was publicly disseminated starting from January 1, 1987 and has no live performance history prior to that date.

About the Russell 2000 TR USD Index

The Russell 2000 TR USD Index is intended to provide a comprehensive and unbiased small-cap barometer and is completely reconstituted annually to ensure larger stocks do not distort the performance and characteristics of the true small-cap opportunity set. The Index includes approximately 2,000 of the smallest securities that represent approximately 6% of the total market capitalization of the investable U.S. equity market. The Index is a total return index calculated by FTSE Russell and reinvests regular cash distributions across the Index. The Index was publicly disseminated starting from January 1, 1984 and has no live performance history prior to that date.

About the Russell 1000 Value TR USD Index

The Russell 1000 Value TR USD Index measures the performance of large- and mid- capitalization U.S. equities that exhibit value characteristics. It includes those Russell 1000® companies with lower price-to-book ratios and lower forecasted growth values. The Index is a total return index calculated by FTSE Russell and reinvests regular cash distributions across the Index. The Index was publicly disseminated starting from January 1, 1987 and has no live performance history prior to that date.

About the MSCI USA Minimum Volatility GR USD Index

The MSCI USA Minimum Volatility GR USD Index is designed to optimize the MSCI USA Index for the lowest absolute volatility with a certain set of constraints. The parent benchmark MSCI USA Index is designed to measure the performance of the large and mid-cap segments of the U.S. equity market. The Index is a total return index calculated by MSCI and reinvests regular cash distributions across the Index. The Index was publicly disseminated starting from June 2, 2008 and has no live performance history prior to that date.

About the MSCI USA Momentum GR USD Index

The MSCI USA Momentum GR USD Index is designed to reflect the performance of an equity momentum strategy over the MSCI USA Index by emphasizing stocks with high price momentum, while maintaining reasonably high trading liquidity, investment capacity and moderate index turnover. The parent benchmark MSCI USA Index is designed to measure the performance of the large and mid-cap segments of the U.S. equity market. The Index is a total return index calculated by MSCI and reinvests regular cash distributions across the Index. The Index was publicly disseminated starting from February 15, 2013 and has no live performance history prior to that date.

About the MSCI USA Sector Neutral Quality GR USD Index

The MSCI USA Sector Neutral Quality GR USD Index aims to capture the performance of large- and mid-cap U.S. equities among the existing constituent securities of the MSCI USA Index that exhibit stronger quality characteristics relative to their peers within the same sector. The parent benchmark MSCI USA Index is designed to measure the performance of the large and mid-cap segments of the U.S. equity market. The Index is a total return index calculated by MSCI and reinvests regular cash distributions across the Index. The Index was publicly disseminated starting from December 14, 2014 and has no live performance history prior to that date.

For more information on the ETNs: Prospectus Supplement

About ETRACS

ETRACS ETNs are senior unsecured notes issued by UBS AG, are traded on NYSE Arca, and can be bought and sold through a broker or financial advisor. An investment in ETRACS ETNs is subject to a number of risks, including the risk of loss of some or all of the investor’s principal, and is subject to the creditworthiness of UBS AG. Investors are not guaranteed any coupon or distribution amount under the ETNs. We urge you to read the more detailed explanation of risks described under “Risk Factors” in the applicable prospectus supplement, or product supplement and pricing supplement, as applicable, for the ETRACS ETN.

UBS AG has filed a registration statement (including a prospectus and supplements thereto) with the Securities and Exchange Commission, or SEC, for the offerings of securities to which this communication relates. Before you invest, you should read the prospectus, along with the applicable prospectus, pricing, or product supplement to understand fully the terms of the securities and other considerations that are important in making a decision about investing in the ETRACS. The applicable offering document for each ETRACS may be obtained by clicking the Prospectus Supplement hyperlink above. You may also get these documents without cost by visiting EDGAR on the SEC website at www.sec.gov. The securities related to the offerings are not deposit liabilities and are not insured or guaranteed by the Federal Deposit Insurance Corporation or any other governmental agency of the United States, Switzerland or any other jurisdiction.

About UBS

UBS provides financial advice and solutions to wealthy, institutional and corporate clients worldwide, as well as private clients in Switzerland. UBS’s strategy is centered on our leading global wealth management business and our premier universal bank in Switzerland, enhanced by Asset Management and the Investment Bank. The bank focuses on businesses that have a strong competitive position in their targeted markets, are capital efficient, and have an attractive long-term structural growth or profitability outlook.

UBS is present in all major financial centers worldwide. It has offices in more than 50 regions and locations, with about 30% of its employees working in the Americas, 31% in Switzerland, 19% in the rest of Europe, the Middle East and Africa and 20% in Asia Pacific. UBS Group AG employs over 68,000 people around the world. Its shares are listed on the SIX Swiss Exchange and the New York Stock Exchange (NYSE).

This material is issued by UBS AG and/or any of its subsidiaries and/or any of its affiliates (“UBS”). Products and services mentioned in this material may not be available for residents of certain jurisdictions. Past performance is not necessarily indicative of future results. Please consult the restrictions relating to the product or service in question for further information. Activities with respect to US securities are conducted through UBS Securities LLC, a US broker/dealer. Member of SIPC (http://www.sipc.org/).

ETRACS ETNs are sold only in conjunction with the relevant offering materials. UBS has filed a registration statement (including a prospectus, as supplemented by the applicable prospectus supplement, or product supplement and pricing supplement, for the offering of the ETRACS ETNs) with the Securities and Exchange Commission (the “SEC”) for the offering to which this communication relates. Before you invest, you should read these documents and any other documents that UBS has filed with the SEC for more complete information about UBS and the offering to which this communication relates. You may get these documents for free by visiting EDGAR on the SEC website at www.sec.gov. Alternatively, you can request the applicable prospectus supplement, or product supplement and pricing supplement, by calling toll-free (+1-877-387 2275). In the US, securities underwriting, trading and brokerage activities and M&A advisor activities are provided by UBS Securities LLC, a registered broker/dealer that is a wholly owned subsidiary of UBS AG, a member of the New York Stock Exchange and other principal exchanges, and a member of SIPC. UBS Financial Services Inc. is a registered broker/dealer and affiliate of UBS Securities LLC.

The IWFL, IWML and IWDL ETNs (the “ETNs”) have been developed solely by UBS. The ETNs are not in any way connected to or sponsored, endorsed, sold or promoted by the London Stock Exchange Group plc and its group undertakings (collectively, the “LSE Group”). FTSE Russell is a trading name of certain of the LSE Group companies. All rights in the FTSE Russell Indices (the “Indices”) vest in the relevant LSE Group company which owns the Index. “Russell®” and “FTSE Russell®” are a trademarks of the relevant LSE Group company and are used by any other LSE Group company under license. The Index is calculated by or on behalf of FTSE International Limited or its affiliate, agent or partner. The LSE Group does not accept any liability whatsoever to any person arising out of (a) the use of, reliance on or any error in the Index or (b) investment in or operation of the ETNs. The LSE Group makes no claim, prediction, warranty or representation either as to the results to be obtained from the ETNs or the suitability of the Index for the purpose to which it is being put by UBS.

The securities referred to herein are not sponsored, endorsed, issued, sold or promoted by MSCI, and MSCI bears no liability with respect to any such securities or any index on which such securities are based. The respective ETN prospectus contains a more detailed description of the limited relationship MSCI has with UBS.

The Dow Jones US Dividend 100 TR USD Index (“Index”) is a product of S&P Dow Jones Indices LLC and has been licensed for use by UBS AG. Copyright © 2021 S&P Dow Jones Indices LLC (“S&P DJI”), a division of S&P Global. All rights reserved. S&P® is a registered trademark of Standard & Poor’s Financial Services LLC (“S&P”) and Dow Jones® is a registered trademark of Dow Jones Trademark Holdings LLC (“Dow Jones”). UBS’s ETRACS Exchange Traded Notes based on the Index are not sponsored, endorsed, marketed or sold by S&P DJI, S&P, Dow Jones, their affiliates or third party licensors and none of such parties make any representation regarding the advisability of investing in such product(s) nor do they have any liability for any errors, omissions, or interruptions of the Indexes.

UBS specifically prohibits the redistribution or reproduction of this material in whole or in part without the prior written permission of UBS and UBS accepts no liability whatsoever for the actions of third parties in this respect.

© UBS 2021. The key symbol, UBS and ETRACS are among the registered and unregistered trademarks of UBS. Other marks may be trademarks of their respective owners. All rights reserved.

 


1 Individual investors should instruct their broker/advisor/custodian to call us or should call together with their broker/advisor/custodian.

Contacts

Media contact

Christina Aquilina

1-212-713-4488

[email protected]

Institutional Investor contact1
+1-877-387 2275

Powered by WPeMatico